To externally validate the presented relationship of serum cTnT and respiratory impairment, future studies should examine serum cTnT in relation to the current benchmarks symptoms such as orthopnea, unrefreshing sleep, daytime somnolence, and any evidence of nocturnal desaturation.12 The gene discussed is TNNT2; the disease is Respiratory insufficiency.